Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 4, 2004Annals of Internal Medicine

Cost-Effectiveness of Cyclooxygenase-2 Inhibitors in Chronic Arthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJames M. PellissierMerck & Co., Inc., Rahway, NJ, USA (United States)DWDouglas J. WatsonCell and Gene Therapy CatapultSKSheldon X. KongBayer (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pellissier et al. (2004) studied this question.

synapsesocial.com/papers/6a70e2cbb27f1581782790cfhttps://doi.org/10.7326/0003-4819-140-9-200405040-00019
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Serological Investigation of Patients with Autoimmune Thrombocytopenia1995 · 44 citations
  2. 2Responsiveness of Thrombotic Thrombocytopenic Purpura to Rituximab and Cyclophosphamide2004 · 29 citations
  3. 3Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs1995 · 1,060 citations